Prafull Raheja is a Cardiology physician affiliated with University of Louisville. OpenAlex indexes 31 publications with 444 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
201 Abraham Flexner Way
Suite 1101
Louisville, KY 402023841
Telephone
502-581-1951Registry record last updated 14 Nov 2016.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202520 payments
- Abbott LaboratoriesProgram year202510 payments
- Novartis Pharmaceuticals CorporationProgram year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.7%Beta blocker22.8%Metoprolol Succinate65%Carvedilol27%Metoprolol Tartrate8%Nebivolol Hcl1%Part D<11 patientsStatin13.9%Atorvastatin Calcium60%Pravastatin Sodium29%Rosuvastatin Calcium9%Simvastatin2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
19.5%P2Y12 inhibitor12.7%Clopidogrel85%Brilinta10%Prasugrel Hcl5%Part D≥191 patientsFactor Xa inhibitor6%Eliquis75%Xarelto25%Part D≥67 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.8%SGLT2 inhibitor2.1%Jardiance52%Farxiga48%Part D≥15 patientsPotassium supplement1.2%Potassium Chloride83%Klor-Con M2017%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TCT-166 Side Branch Outcomes in Severely Calcified Coronary Lesions: The Impact of Orbital and Rotational Atherectomy
Journal of the American College of Cardiology
2025 - A-66 | Thrombolytics Assisted Invasive Approach versus Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction: An Updated Meta-Analysis of Randomized Controlled Trials
Journal of the Society for Cardiovascular Angiography & Interventions
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Franciosi, MD
University of Louisville
Matthew Cave, MD
University of Louisville
David Tollerud, MD
University of Louisville
Goetz Kloecker, MD
University of Louisville
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”